Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zayna Shaheen"'
Autor:
Robert J. Kimmerling, Mark M. Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C. Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S. Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A. Criscitiello, Ruben Niesvizky, Marlise R. Luskin, Samir Parekh, Cara A. Rosenbaum, Anobel Tamrazi, Clifford A. Reid
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-14 (2022)
A pipeline for drug sensitivity testing using cell mass from sample collection to data analysis is presented.
Externí odkaz:
https://doaj.org/article/4fdd94008c854d24ab6da10668f5587e
Autor:
Robert J. Kimmerling, Mark M. Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C. Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S. Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A. Criscitiello, Ruben Niesvizky, Marlise R. Luskin, Samir Parekh, Cara A. Rosenbaum, Anobel Tamrazi, Clifford A. Reid
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/8f694796722146e58147a51a6af93ce3
Autor:
Anobel Tamrazi, Srividya Sundaresan, Amin Parvizi, Andrea Eller, Juanita Fujii, Zayna Shaheen, Ann Campbell
Publikováno v:
Cancer Treatment and Research Communications, Vol 33, Iss , Pp 100626- (2022)
Small pulmonary nodules (≤1.5 cm) are frequently detected on routine chest imaging and lung cancer screening studies. Our goal was to determine the clinical value of CT-guided core needle biopsy (CNB) in the evaluation of such nodules. In this sing
Externí odkaz:
https://doaj.org/article/7b3fd288b3104dd1884cfdc982d865ae
Autor:
Robert Kimmerling, Mark Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Katie Katsis, Audrey Guo, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Anobel Tamrazi, Cliff Reid
Publikováno v:
Cancer Research. 83:2176-2176
Existing predictive biomarkers for immune checkpoint blockade (ICB) therapies that rely on characterization of tumor genomics or immunohistological assessment of the tumor microenvironment have demonstrated mixed success, with no single biomarker pro